These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23484621)

  • 21. Metabolic stress, IAPP and islet amyloid.
    Montane J; Klimek-Abercrombie A; Potter KJ; Westwell-Roper C; Bruce Verchere C
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():68-77. PubMed ID: 22928566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophages and islet inflammation in type 2 diabetes.
    Eguchi K; Manabe I
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
    Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
    J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.
    Gorus FK; Sodoyez JC; Pipeleers DG; Keymeulen B; Foriers A; Van Schravendijk CF
    Diabetologia; 1992 Nov; 35(11):1080-6. PubMed ID: 1473619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.
    Cobo-Vuilleumier N; Lorenzo PI; Rodríguez NG; Herrera Gómez IG; Fuente-Martin E; López-Noriega L; Mellado-Gil JM; Romero-Zerbo SY; Baquié M; Lachaud CC; Stifter K; Perdomo G; Bugliani M; De Tata V; Bosco D; Parnaud G; Pozo D; Hmadcha A; Florido JP; Toscano MG; de Haan P; Schoonjans K; Sánchez Palazón L; Marchetti P; Schirmbeck R; Martín-Montalvo A; Meda P; Soria B; Bermúdez-Silva FJ; St-Onge L; Gauthier BR
    Nat Commun; 2018 Apr; 9(1):1488. PubMed ID: 29662071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity.
    Donath MY; Dalmas É; Sauter NS; Böni-Schnetzler M
    Cell Metab; 2013 Jun; 17(6):860-872. PubMed ID: 23747245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet inflammation in type 2 diabetes.
    Marchetti P
    Diabetologia; 2016 Apr; 59(4):668-72. PubMed ID: 26894276
    [No Abstract]   [Full Text] [Related]  

  • 28. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dectin-2 Deficiency Promotes Proinflammatory Cytokine Release From Macrophages and Impairs Insulin Secretion.
    Fujita M; Miyazawa T; Uchida K; Uchida N; Haji S; Yano S; Iwahashi N; Hatayama T; Katsuhara S; Nakamura S; Takeichi Y; Yokomoto-Umakoshi M; Miyachi Y; Sakamoto R; Iwakura Y; Ogawa Y
    Endocrinology; 2023 Nov; 165(1):. PubMed ID: 38038367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
    Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JA
    Diabetes Care; 2008 Feb; 31 Suppl 2():S161-4. PubMed ID: 18227479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-melanocyte stimulating hormone preserves islet graft survival through down-regulation of Toll-like receptors.
    Jung EJ; Kim SC; Jeong SH; Lee JY; Han DJ
    Transplant Proc; 2012 May; 44(4):1086-90. PubMed ID: 22564632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.
    Sharma PR; Mackey AJ; Dejene EA; Ramadan JW; Langefeld CD; Palmer ND; Taylor KD; Wagenknecht LE; Watanabe RM; Rich SS; Nunemaker CS
    Endocrinology; 2015 Sep; 156(9):3147-56. PubMed ID: 26018251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone treatment does not decrease amyloid deposition in transplanted islets from transgenic mice expressing human islet amyloid polypeptide.
    Udayasankar J; Zraika S; Aston-Mourney K; Subramanian SL; Brooks-Worrell BM; Taborsky GJ; Hull RL
    Transplant Proc; 2013 Mar; 45(2):574-9. PubMed ID: 23267797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.
    Donath MY; Størling J; Maedler K; Mandrup-Poulsen T
    J Mol Med (Berl); 2003 Aug; 81(8):455-70. PubMed ID: 12879149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.
    Hasnain SZ; Borg DJ; Harcourt BE; Tong H; Sheng YH; Ng CP; Das I; Wang R; Chen AC; Loudovaris T; Kay TW; Thomas HE; Whitehead JP; Forbes JM; Prins JB; McGuckin MA
    Nat Med; 2014 Dec; 20(12):1417-26. PubMed ID: 25362253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet inflammation in type 2 diabetes and physiology.
    Eguchi K; Nagai R
    J Clin Invest; 2017 Jan; 127(1):14-23. PubMed ID: 28045399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
    Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
    J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
    Tomita T
    Islets; 2011; 3(4):166-74. PubMed ID: 21633185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.